Glucanix-Met is a combination antidiabetic medication containing 50MG of glimepiride and 1000MG of metformin hydrochloride. This dual-action tablet is designed to effectively manage type 2 diabetes by lowering blood glucose levels through two distinct mechanisms. Glimepiride stimulates insulin production from pancreatic beta cells, while metformin reduces hepatic glucose production and improves insulin sensitivity in peripheral tissues. This combination therapy is particularly beneficial for patients who require additional glycemic control beyond what metformin alone can provide.